A Prospective, Randomized Study to Determine the Effect of Ezetimibe in Addition to Rosuvastatin on Lipids in Participants With the Hypercholesterolemia Associated With HIV Antiretroviral Therapy.
Phase of Trial: Phase IV
Latest Information Update: 27 Jan 2016
At a glance
- Drugs Ezetimibe (Primary) ; Rosuvastatin
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 31 Dec 2015 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 21 Nov 2011 Company added as trial sponsor as reported by ClinicalTrials.gov.